The second CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" for blood ...

A "living drug" Qartemi has been approved for blood cancer patients in India who suffer from an advanced or relapsed stage of ...

Three Indian women have been honoured on the Forbes 50 Over 50 Global list, including a founder, an activist, and a Bengaluru-based billionaire ...

India's role in affordable cell and gene therapies, including CAR-T, and the need for a mission mode approach.

Synthetic biology startup Fermbox works in an asset-light business model and has raised $2.5 Mn so far to build its tech capabilities ...

The third quarter earnings season is ongoing with key companies like Coal India, Tata Steel, and Indian Oil set to announce ...

Syngene reported 18% YoY growth in Q3FY25 net profit. Revenue rose 11% YoY. EBITDA margin improved to 31.4%. Company expects ...